Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04361916

Acronym

Mon-Covid

Enrollment

Registered

2020-04-24

Start date

2020-04-21

Completion date

2020-06-30

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

COVID-19, oximetry, active monitoring, home care

Brief summary

Starting an early home management and monitoring of patients with suspected or confirmed COVID-19 to ensure a rapid and adequate transfer to hospital care. Assess the feasibility of home monitoring in a pilot study to possibly extend it to a larger scale.

Detailed description

The study will include adult patients with suspected or confirmed COVID-19 for whom home care is considered appropriate. Trained health workers will conduct home care monitoring of pulmonary performance using oximetry, Quick Walk Test and Single Breath Count. Monitoring will be done daily until disappearance of symptoms or hospitalization which will be requested by health workers or study coordination board on the basis of the monitoring results (blood oxygen level SpO2\< 90% OR SpO2\> 90% with desaturation index of at least 5% at Quick Walk Test)

Interventions

OTHERhome care monitoring

home care active monitoring of patients with suspected of confirmed COVID-19

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Intervention model description

single arm, open label trial on active home monitoring strategy

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

adult patients with suspected or confirmed COVID-19 for whom home care is considered appropriate.

Exclusion criteria

physical, mental or temporary impairments that preclude the conduction of the test

Design outcomes

Primary

Measure	Time frame	Description
SpO2 at hospital entry	24 hours	Peripheral blood saturation measured on arrival to the hospital

Secondary

Measure	Time frame	Description
in-hospital mortality	30 days	death during hospitalization
need of intubation	30 days	need of intubation
Percentage of hospitalized patients among those with recommendation of hospitalization	30 days	To evaluate the feasibility of active monitoring, we will consider the percentage of patients who will be actually hospitalized within 24 hours after the recommendation of hospitalization

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026